Early contraceptive failure of Implanon® in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz

Journal of Family Planning and Reproductive Health Care

Volumn 33, Issue 4, 2007, Pages 277-278

  Matiluko, Adetunji A ^a   Soundararjan, Lakshmi ^b   Hogston, Patrick ^b  

^a DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; EFAVIRENZ; ETONOGESTREL; IBUPROFEN; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CONTRACEPTION; ECTOPIC PREGNANCY; FEMALE; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPLANT; LAPAROTOMY; NAUSEA; PAIN; ULTRASOUND;

EID: 35348968894     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118907782101724     Document Type: Article

References (10)

1. Implanon® Summary of Product Characteristics. http://emc.medicines. org.uk/emc/assets/c/html/displaydoc.asp?documentid=5382 [Accessed 24 February 2007].
2. Makarainen L, Van Beek A, Tuomivaara L, Asplund B, Coelingh-Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 1998; 69: 714-721.
3. Agrawal A, Robinson C. An assessment of the first 3 years' use of Implanon in Luton. J Fam Plann Reprod Health Care 2005; 31: 310-312.
4. Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E. Insertion problems, removal problems, and contraception failures with Implanon. Gynecol Obstet Fertil 2005; 33: 986-990.
5. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005; 71: 306-308.
6. Smith PF, DiCenzo R, Morse GD. Clinical pharmacokinetic of non-nucleoside reverse transcriptase inhibitors. Clin Pharmacokinet 2001; 40: 890-905.
7. Sustiva® (efavirenz) Prescribing Information. http://www.bms.com/cgi- bin/anybin.pl?sql=select%20PPI%20from% 20TB_PRODUCT_PPI%20where%20PPI_SEQ= 94&key=PPI http://www.Sustiva.com [Accessed 24 February 2007].
8. Davis K, Weller S. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31: 272-279.
9. Magalhaes J, Amaral E, Giraldo PC, Simoes JA. HIV infection in women: impact on contraception. Contraception 2002; 66: 87-91.
10. Mitchell HS, Stephens E. Contraceptive choices for HIV positive women. Sex Transm Infect 2004; 80: 167-173.